NASDAQ: ACET
Adicet Bio Inc Stock Ownership - Who owns Adicet Bio?

Insider buying vs selling

Have Adicet Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Blake AftabChief Scientific Officer2025-01-246,270$0.92
$5.78kSell
Brian Nicholas HarveyChief Financial Officer2025-01-248,752$0.92
$8.07kSell
Don HealeyChief Technology Officer2025-01-248,560$0.92
$7.89kSell
Chen SchorPresident CEO2025-01-2428,101$0.92
$25.91kSell

1 of 1

ACET insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACET insiders and whales buy or sell their stock.

ACET Shareholders

What type of owners hold Adicet Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC13.84%11,447,140$7.17MInstitution
Tang Capital Management LLC9.94%8,223,612$5.15MInstitution
Ra Capital Management LP9.12%7,541,000$4.72MInstitution
Jonathan Silverstein5.84%4,830,387$3.02MInsider
Goldman Sachs Group Inc4.61%3,816,556$2.39MInstitution
Vanguard Group Inc3.88%3,205,882$2.01MInstitution
Carlyle Group Inc3.57%2,948,718$1.85MInstitution
Aquilo Capital Management LLC2.97%2,456,194$1.54MInstitution
Andrew Sinclair2.58%2,133,085$1.34MInsider
Puretech Health LLC2.56%2,119,696$1.33MInsider

1 of 3

ACET vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACET67.53%19.44%Net Selling
KLRS4.63%95.37%Net Selling
RENB12.79%67.38%Net Selling
CUE15.13%7.51%Net Buying
VRCA31.87%53.14%Net Selling

Adicet Bio Stock Ownership FAQ

Who owns Adicet Bio?

Adicet Bio (NASDAQ: ACET) is owned by 67.53% institutional shareholders, 19.44% Adicet Bio insiders, and 13.03% retail investors. Jonathan Silverstein is the largest individual Adicet Bio shareholder, owning 4.83M shares representing 5.84% of the company. Jonathan Silverstein's Adicet Bio shares are currently valued at $2.95M.

If you're new to stock investing, here's how to buy Adicet Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.